Therefore, obtaining new evidence from clinical trials and real-world settings should be prioritized to help better position thrombopoietin analogs as the new standard treatment for CLD patients with TCP undergoing invasive procedures. Here, THPO is linked to congenital secretory chloride diarrhea 1.